Latest News

  • HudsonAlpha, SAW Dx, Entasis, And More: News From February 2019

    Diagnostics World | February featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including HudsonAlpha, SAW Dx, Entasis, and more.

    Feb 27, 2019
  • New Robotic Sensor Technology Can Diagnose Reproductive Health Problems In Real-Time

    Diagnostics World News Brief | Technology being developed by researchers at Imperial College London and The University of Hong Kong can be used to measure hormones that affect fertility, sexual development, and menstruation more quickly and cheaply than current methods.

    Feb 22, 2019
  • Molecular Medicine Tri-Con: Diagnostics, Drug Discovery Comes To San Francisco

    Diagnostics World | The Molecular Medicine Tri-Conference will take place in San Francisco in March. Thought leaders throughout biotech, pharma, and academia from around the world will discuss and present the latest innovations in the fields of drug discovery, development, and diagnostics.

    Feb 21, 2019
  • Autism Blood Test Becomes Reality, Others On The Horizon

    Diagnostics World | Autism spectrum disorder (ASD) could benefit from new and improved diagnostic methods, and the arrival of a newly commercialized blood test—along with other efforts headed toward a similar end goal—could be nudging the field toward earlier detection and intervention.

    Feb 20, 2019
  • Broad Institute Launches Gerstner Center For Cancer Diagnostics

    Diagnostics World News Brief | The Broad Institute of MIT and Harvard announced the launch of the Gerstner Center for Cancer Diagnostics at the Broad Institute. The Gerstner Center aims to advance blood-based biopsies for tracking disease progression and pursue other cancer diagnostics that have the potential to benefit millions of patients worldwide.

    Feb 19, 2019
  • Mayo Amps Up Predictive Power Of Its Kidney Stone Recurrence Tool

    Diagnostics World News | Mayo researchers have significantly improved their predictive Recurrence of Kidney Stone (ROKS) tool by making it applicable to patients who have already had two or more attacks. The revised model, developed by a new study published in Mayo Clinic Proceedings, uses 13 readily available clinical characteristics of stone formers.

    Feb 14, 2019
  • Novel Technologies, Machine Learning Are The Keys To Improving Acute Infection Diagnostics

    Diagnostics World News | Diagnostics for acute infections and sepsis typically focus on “finding the bug,” but most patients with infections do not have pathogens in their bloodstream. Novel technologies coupled with machine learning are the answer for physicians when seeing a patient they suspect of having an acute infection.

    Feb 13, 2019
  • AI A Useful But Not Error-Proof Diagnostic Tool In Melanoma

    Diagnostics World | AI’s ability to diagnose melanoma with higher fidelity illustrates the potential impact on patient outcomes, but its usefulness has met some challenges along the way.

    Feb 7, 2019
  • The Lab’s Role In Promoting Better Asthma Outcomes

    Diagnostics World Contributed Commentary | As the healthcare system moves from fee-for-service to value-based care, we must do our part to be advocates for new diagnostic tests that can help the model mature and become more efficient and effective. Aiding in the early diagnosis of asthma is one example of how we can help to meet the Triple Aim goals to improve patient experience of care, improve the health of populations, and reduce the per capita costs of care.

    Feb 5, 2019
  • Industry Objects To CMS Guidance On NGS Testing

    Diagnostics World Brief  Members of 63 leading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid Services (CMS) to revise its interpretation of the National Coverage Determination (NCD) for Next Generation Sequencing (NGS). In a letter to CMS Administrator Seema Verma, the organizations expressed serious concerns that the overly broad interpretation will restrict patient access to medically necessary and relevant clinical tests and adversely impact cancer care and outcomes.

    Feb 1, 2019
  • Rapid Response And The Outbreaks To Come

    Diagnostics World | According to the director of the Point-of-Care Testing Center for Teaching and Research at the UC Davis Health System, we should be asking ourselves why we have not reached out and teamed up with the public health profession in America to educate and get ready for outbreaks in our communities by enabling everyone with point-of-care testing.

    Feb 1, 2019